AINI

News

CD19 mRNA quantification improves rituximab treatment-to-target approach: A proof of concept study

CD19 mRNA quantification improves rituximab treatment-to-target approach: A proof of concept study
Marnetto et al.
Journal of Neuroimmunology; December 2014

We compared pre-amplification (PA) RT-PCR blood

The following content is accessible for members only, please sign in.
Loading…